(Q37532557)

20 August 2017

1 reference

title

New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy (English)

1 reference

chronic obstructive pulmonary disease

20 August 2017

main subject

1 reference

Satomi Onoue

1

1 reference

20 August 2017

Shingen Misaka

series ordinal

2

1 reference

20 August 2017

Yohei Kawabata

series ordinal

3

1 reference

20 August 2017

Shizuo Yamada

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Expert Opinion on Drug Delivery

20 August 2017

published in

1 reference

20 August 2017

volume

6

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

793-811

1 reference

Burden and clinical features of chronic obstructive pulmonary disease (COPD).

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Global burden of COPD: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Epidemiology of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

The global burden of disease, 1990–2020

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Mediators of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

COPD: current therapeutic interventions and future approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Idealhalers or realhalers? A comparison of Diskus and Turbuhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Mechanisms of cigarette smoke-induced COPD: insights from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Cytokines and therapy in COPD: a promising combination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Emerging treatments for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

The puzzle of asthma treatment: animal models to genetic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

The mechanisms, diagnosis, and management of severe asthma in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Recent advances in the development of anti-allergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Formoterol and tiotropium compared with tiotropium alone for treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

21 January 2018

Theophylline for COPD.

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Corticosteroids: potential beta2-agonist and anticholinergic interactions in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Pharmacology of airway inflammation in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Corticosteroid resistance in airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Vasoactive intestinal polypeptide and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Therapy for chronic obstructive pulmonary disease in the 21st century.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

21 January 2018

New treatments for COPD.

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Emerging pharmacotherapies for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Antiinflammatory therapies other than corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

PDE4 inhibitors: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Neutrophils and the pathogenesis of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Kinase inhibitors and airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Dry powder inhalers for optimal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Assessment of patient performance of the HandiHaler® compared with the metered dose inhaler four weeks after instruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Dry powder inhalers for pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Improved inhalation behavior of steroid KSR-592 in vitro with Jethaler by polymorphic transformation to needle-like crystals (beta-form).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

The lung as a route for systemic delivery of therapeutic proteins and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

The effect of flow rate on drug delivery from the Pulvinal, a high-resistance dry powder inhaler.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Airmax: a multi-dose dry powder inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

The efficacy of a new salbutamol metered-dose powder inhaler in comparison with two other inhaler devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Clickhaler dry powder inhaler: focussed in vitro proof of principle evaluation of a new chemical entity for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Erythritol-based dry powder of glucagon for pulmonary administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Particle interactions involved in aerosol dispersion of ternary interactive mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

The influence of carrier and drug morphology on drug delivery from dry powder formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Inhaled insulin for diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Chitosan-modified dry powder formulations for pulmonary gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

A preliminary pharmacokinetic study of liposomal leuprolide dry powder inhaler: a technical note

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Nebulization of liposome encapsulated antitubercular drugs in guinea pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Liposome technology for drug delivery against mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Polymer based drug delivery systems for mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Production and characterization of a budesonide nanosuspension for pulmonary administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

In vitro evaluation of the effect of cyclodextrin complexation on pulmonary deposition of a peptide, cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903089310

10.1517/17425240903089310

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference